Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harmony Biosciences Holdings (HRMY) Current Assets (2019 - 2025)

Historic Current Assets for Harmony Biosciences Holdings (HRMY) over the last 7 years, with Q3 2025 value amounting to $838.8 million.

  • Harmony Biosciences Holdings' Current Assets rose 6056.51% to $838.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $838.8 million, marking a year-over-year increase of 6056.51%. This contributed to the annual value of $579.3 million for FY2024, which is 2841.73% up from last year.
  • As of Q3 2025, Harmony Biosciences Holdings' Current Assets stood at $838.8 million, which was up 6056.51% from $691.4 million recorded in Q2 2025.
  • Harmony Biosciences Holdings' Current Assets' 5-year high stood at $838.8 million during Q3 2025, with a 5-year trough of $177.7 million in Q1 2021.
  • Its 5-year average for Current Assets is $436.5 million, with a median of $451.1 million in 2023.
  • As far as peak fluctuations go, Harmony Biosciences Holdings' Current Assets crashed by 381.67% in 2021, and later surged by 6056.51% in 2025.
  • Harmony Biosciences Holdings' Current Assets (Quarter) stood at $284.4 million in 2021, then soared by 40.73% to $400.3 million in 2022, then grew by 12.69% to $451.1 million in 2023, then grew by 28.42% to $579.3 million in 2024, then soared by 44.81% to $838.8 million in 2025.
  • Its Current Assets stands at $838.8 million for Q3 2025, versus $691.4 million for Q2 2025 and $642.7 million for Q1 2025.